Dr. Sudha Sinha

Dr. Sudha Sinha is a Clinical Director, Head of Department, and Senior Consultant in Medical Oncology with over 23 years of clinical experience spanning both the United States and India. She holds American Board Certifications in Internal Medicine, Hematology, and Medical Oncology, along with ECFMG Certification—credentials reflecting her rigorous training at prestigious American institutions including St. Barnabas Medical Center and Tufts University School of Medicine.

Dr. Sinha brings deep expertise in the management of solid tumors, hematologic malignancies, and complex cancer care. Her clinical focus encompasses chemotherapy, cancer immunotherapy, CAR-T cell therapy, and targeted therapy across a broad spectrum of malignancies including breast cancer, gynecologic cancers, leukemia, myeloma, lung cancers, gastrointestinal cancers, and sarcomas. She is recognized for her evidence-based, compassionate approach to treatment and her commitment to holistic cancer management, including palliative care and fertility preservation for women with cancer.

Dr. Sinha has established herself as a trusted oncologist for international patients seeking specialized cancer care. Her bilingual expertise (English and regional Indian languages) and experience managing patients from the Gulf, Africa, and across the Indian subcontinent enable her to provide culturally sensitive, personalized treatment plans. She works seamlessly with international medical coordinators to ensure a smooth experience for patients traveling to India for cancer treatment.

At Yashoda Hospital in Hyderabad, she leads a comprehensive oncology service equipped with modern diagnostic and treatment technologies. Yashoda Hospital is known for its patient-centered care, international quality standards, and seamless coordination for international patients. The hospital's location in Hyderabad—a major medical hub with excellent connectivity—makes it an ideal destination for cancer patients seeking world-standard care at affordable costs. International patients benefit from dedicated support services, transparent communication, and evidence-based treatment protocols overseen by Dr. Sinha and her team.

For patients seeking advanced cancer treatment with a physician who combines American-trained rigor with deep Indian clinical experience, Dr. Sinha offers a compelling option. Her track record of managing complex cases and her commitment to staying current with the latest oncologic advances make her a preferred choice for international medical tourists seeking comprehensive, compassionate cancer care in India.